Clinical trial NCT05812469: A Psychoeducational Intervention for Brain Awareness, Metacognition, Self-efficacy and Treatment Motivation
Official title: The Effect of a Psychoeducational Intervention for Brain Awareness Applied on Patients With Alcohol and Substance Use Disorders on Metacognition, Self-efficacy and Treatment Motivation
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Substance Use Disorders
Alcohol Use Disorder
Keywords: Brain Awareness
Psychoeducation
Metacognition
Self-efficacy
Treatment Motivation
Lead sponsor: Istanbul University - Cerrahpasa
Sponsor class: OTHER
First posted: 2023-04-13
Enrollment: 77
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: It is an experimentally designed study with a randomized control group and repeated measurements (pre-test, mid-test, post-test).
Primary purpose: TREATMENT

Brief summary: The aim of this study is to examine the effect of brain awareness intervention on metacognition, self-efficacy and treatment motivation in patients with alcohol and substance use disorders. It is an experimentally designed study with a randomized control group and repeated measurements (pre-test, mid-test, post-test).

Detailed description: The aim of this study is to examine the effect of brain awareness intervention on metacognition, self-efficacy and treatment motivation in patients with alcohol and substance use disorders. It is an experimentally designed study with a randomized control group and repeated measurements (pre-test, mid-test, post-test). 77 inpatients at the Alcohol and Drug Addiction Treatment and Research Center included between April and October 2021. In addition to standard treatment, psychoeducation and counseling provided as part of the Brain Awareness Intervention for the experimental group of 39 patients. The control group of 38 patients will receive education about Being Healthy in addition to standard treatment and standard follow-up. Patients' pathological metacognitive activities, self-efficacy perceptions and treatment motivation will assessed with the Metacognition Scale-30, Self-Efficacy Scale and Treatment Motivation Questionnaire using one-way and two-way repeated measures analysis.

Eligibility criteria: Inclusion Criteria:

1. Being between the ages of 18-65 and able to read and write
2. Inpatient treatment with alcohol or substance abuse problem
3. To not have a psychiatric (severe depression, bipolar disorder or psychosis) or mental illness that would prevent participation in the study

Exclusion Criteria:

1. Failure to participate in more than one session despite agreeing to participate in the research
2. Taking the decision to terminate treatment or early discharge by violating treatment rules during the treatment process
3. Not participating in post-discharge follow-up or post-test application

Primary outcomes:
measure: Metacognition Scale-30
timeFrame: 72 Hours
measure: Self-Efficacy-Efficacy Scale
timeFrame: 72 Hours
measure: Treatment Motivation Questionnaire
timeFrame: 72 Hours
Secondary outcomes:
Other outcomes:
Locations:
city: Çorum
country: Turkey
facility: Halil Ibrahim Olcum
Study officials:
References: